Appointment booking for Dr. Sushil Mehrotra, MD is currently not available.Dr. Sushil Mehrotra, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Sushil Mehrotra, MD (he/him) is a Hematologist in Wheeling, WV with over 18 years of experience. What is your opinion of Dr. Sushil Mehrotra, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sushil Mehrotra, MD has received over $2,823 which includes payments from the following companies:
$591.88 from Novartis Pharmaceuticals Corporation
$296.92 from Amgen Inc.
$279.13 from Incyte Corporation
$208.77 from Genentech USA, Inc.
$170.07 from Janssen Biotech, Inc.
$118.41 from Janssen Pharmaceuticals, Inc
$117.66 from Merck Sharp & Dohme Corporation
$100.47 from Boehringer Ingelheim Pharmaceuticals, Inc.
$99.99 from Pharmacyclics LLC, An AbbVie Company
$97.96 from Abbott Laboratories
$77.61 from Pfizer Inc.
$74.19 from CSL Behring
$70.52 from Ironwood Pharmaceuticals, Inc
$58.45 from Covidien LP
$58.05 from sanofi-aventis U.S. LLC
$56.76 from Depomed, Inc.
$39.05 from Eisai Inc.
$37.01 from AstraZeneca Pharmaceuticals LP
$34.34 from Baxter Healthcare
$32.14 from TESARO, Inc.
Payments received by Dr. Sushil Mehrotra, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!